Saflufenacil
- Product NameSaflufenacil
- CAS372137-35-4
- CBNumberCB72572731
- MFC17H17ClF4N4O5S
- MW500.85
- MDL NumberMFCD16875523
- MOL File372137-35-4.mol
Chemical Properties
Density | 1.542±0.06 g/cm3(Predicted) |
solubility | DMSO ()Slightly, Methanol (Slightly) |
pka | 4.24±0.40(Predicted) |
BRN | 11326826 |
InChI | InChI=1S/C17H17ClF4N4O5S/c1-8(2)25(4)32(30,31)23-15(28)9-5-12(11(19)6-10(9)18)26-14(27)7-13(17(20,21)22)24(3)16(26)29/h5-8H,1-4H3,(H,23,28) |
InChIKey | GNHDVXLWBQYPJE-UHFFFAOYSA-N |
SMILES | C(NS(N(C)C(C)C)(=O)=O)(=O)C1=CC(N2C(=O)N(C)C(C(F)(F)F)=CC2=O)=C(F)C=C1Cl |
FDA UNII | 189U20M808 |
EPA Substance Registry System | Benzamide, 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]- (372137-35-4) |
Safety
Symbol(GHS) | |
Signal word | Warning |
Hazard statements | H410 |
Precautionary statements | P273-P391-P501 |
Hazard Codes | N |
Risk Statements | 50/53 |
Safety Statements | 61 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | 2 |